ACAD
Acadia Pharmaceuticals Inc

13,129
$21.52
Today
·Closed $22.20
$0.6849
(3.08%)
After Hours
Updated: 11:50 PM UTC
13,129
Mkt Cap
$3.82B
Volume
1.43M
52W High
$26.65
52W Low
$13.40
PE Ratio
14.28
ACAD Fundamentals
Price
$22.20
Prev Close
$22.57
Open
$22.80
50D MA
$22.55
Beta
1.01
Avg. Volume
1.95M
EPS (Annual)
$1.36
P/B
4.09
Rev/Employee
$1.46M
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
654

Frequently Asked Questions

What is Market Cap of Acadia Pharmaceuticals Inc?
What is the 52-week high for Acadia Pharmaceuticals Inc?
What is the 52-week low for Acadia Pharmaceuticals Inc?
What is Acadia Pharmaceuticals Inc stock price today?
What was Acadia Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Acadia Pharmaceuticals Inc?
What is the Price-to-Book ratio of Acadia Pharmaceuticals Inc?
What is the 50-day moving average of Acadia Pharmaceuticals Inc?
How many employess does Acadia Pharmaceuticals Inc has?

Extremely Bullish

77

High

67

Latest ACAD News

View
Analysts Issue Forecasts for ACAD Q1 Earnings
MarketBeat·2d ago
News Placeholder
Leerink Partnrs Has Positive Outlook for ACAD Q4 Earnings
MarketBeat·2d ago
News Placeholder
ACADIA Pharmaceuticals (NASDAQ:ACAD) Raised to Buy at Wall Street Zen
MarketBeat·3d ago
News Placeholder

Advertisement|Remove ads.

Advertisement|Remove ads.